Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)

Clinical trial NCT01190072 · TERMINATED

Trial details

NCT number: NCT01190072
Sponsor: AstraZeneca
Status: TERMINATED
Study type: OBSERVATIONAL

Coronary Artery Disease

Start date: 2010-09-01
Primary completion: 2011-03-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.